Ending of preventable deaths from pneumonia and diarrhoea: An achievable goal

Mickey Chopra, Elizabeth Mason, John Borrazzo, Harry Campbell, Igor Rudan, Li Liu, Robert E Black, Zulfiqar A. Bhutta

Research output: Contribution to journalArticle

Abstract

Global under-5 mortality has fallen rapidly from 12 million deaths in 1990, to 6·9 million in 2011; however, this number still falls short of the target of a two-thirds reduction or a maximum of 4 million deaths by 2015. Acceleration of reductions in deaths due to pneumonia and diarrhoea, which together account for about 2 million child deaths every year, is essential if the target is to be met. Scaling up of existing interventions against the two diseases to 80% and immunisation to 90% would eliminate more than two-thirds of deaths from these two diseases at a cost of US$6·715 billion by 2025. Modelling in this report shows that if all countries could attain the rates of decline of the regional leaders, then cause-specific death rates of fewer than three deaths per 1000 livebirths from pneumonia and less than one death per 1000 livebirths from diarrhoea could be achieved by 2025. These rates are those at which preventable deaths have been avoided. Increasing of awareness of the size of the problem; strengthening of leadership, intersectoral collaboration, and resource mobilisation; and increasing of efficiency through the selection of the optimum mix of a growing set of cost-effective interventions depending on local contexts are the priority actions needed to achieve the goal of ending preventable deaths from pneumonia and diarrhoea by 2025.

Original languageEnglish (US)
Pages (from-to)1499-1506
Number of pages8
JournalThe Lancet
Volume381
Issue number9876
DOIs
StatePublished - 2013

Fingerprint

Diarrhea
Pneumonia
Costs and Cost Analysis
Mortality
Cause of Death
Immunization

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chopra, M., Mason, E., Borrazzo, J., Campbell, H., Rudan, I., Liu, L., ... Bhutta, Z. A. (2013). Ending of preventable deaths from pneumonia and diarrhoea: An achievable goal. The Lancet, 381(9876), 1499-1506. https://doi.org/10.1016/S0140-6736(13)60319-0

Ending of preventable deaths from pneumonia and diarrhoea : An achievable goal. / Chopra, Mickey; Mason, Elizabeth; Borrazzo, John; Campbell, Harry; Rudan, Igor; Liu, Li; Black, Robert E; Bhutta, Zulfiqar A.

In: The Lancet, Vol. 381, No. 9876, 2013, p. 1499-1506.

Research output: Contribution to journalArticle

Chopra, M, Mason, E, Borrazzo, J, Campbell, H, Rudan, I, Liu, L, Black, RE & Bhutta, ZA 2013, 'Ending of preventable deaths from pneumonia and diarrhoea: An achievable goal', The Lancet, vol. 381, no. 9876, pp. 1499-1506. https://doi.org/10.1016/S0140-6736(13)60319-0
Chopra, Mickey ; Mason, Elizabeth ; Borrazzo, John ; Campbell, Harry ; Rudan, Igor ; Liu, Li ; Black, Robert E ; Bhutta, Zulfiqar A. / Ending of preventable deaths from pneumonia and diarrhoea : An achievable goal. In: The Lancet. 2013 ; Vol. 381, No. 9876. pp. 1499-1506.
@article{156959469a6b4602b2a5aec80ae557bb,
title = "Ending of preventable deaths from pneumonia and diarrhoea: An achievable goal",
abstract = "Global under-5 mortality has fallen rapidly from 12 million deaths in 1990, to 6·9 million in 2011; however, this number still falls short of the target of a two-thirds reduction or a maximum of 4 million deaths by 2015. Acceleration of reductions in deaths due to pneumonia and diarrhoea, which together account for about 2 million child deaths every year, is essential if the target is to be met. Scaling up of existing interventions against the two diseases to 80{\%} and immunisation to 90{\%} would eliminate more than two-thirds of deaths from these two diseases at a cost of US$6·715 billion by 2025. Modelling in this report shows that if all countries could attain the rates of decline of the regional leaders, then cause-specific death rates of fewer than three deaths per 1000 livebirths from pneumonia and less than one death per 1000 livebirths from diarrhoea could be achieved by 2025. These rates are those at which preventable deaths have been avoided. Increasing of awareness of the size of the problem; strengthening of leadership, intersectoral collaboration, and resource mobilisation; and increasing of efficiency through the selection of the optimum mix of a growing set of cost-effective interventions depending on local contexts are the priority actions needed to achieve the goal of ending preventable deaths from pneumonia and diarrhoea by 2025.",
author = "Mickey Chopra and Elizabeth Mason and John Borrazzo and Harry Campbell and Igor Rudan and Li Liu and Black, {Robert E} and Bhutta, {Zulfiqar A.}",
year = "2013",
doi = "10.1016/S0140-6736(13)60319-0",
language = "English (US)",
volume = "381",
pages = "1499--1506",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9876",

}

TY - JOUR

T1 - Ending of preventable deaths from pneumonia and diarrhoea

T2 - An achievable goal

AU - Chopra, Mickey

AU - Mason, Elizabeth

AU - Borrazzo, John

AU - Campbell, Harry

AU - Rudan, Igor

AU - Liu, Li

AU - Black, Robert E

AU - Bhutta, Zulfiqar A.

PY - 2013

Y1 - 2013

N2 - Global under-5 mortality has fallen rapidly from 12 million deaths in 1990, to 6·9 million in 2011; however, this number still falls short of the target of a two-thirds reduction or a maximum of 4 million deaths by 2015. Acceleration of reductions in deaths due to pneumonia and diarrhoea, which together account for about 2 million child deaths every year, is essential if the target is to be met. Scaling up of existing interventions against the two diseases to 80% and immunisation to 90% would eliminate more than two-thirds of deaths from these two diseases at a cost of US$6·715 billion by 2025. Modelling in this report shows that if all countries could attain the rates of decline of the regional leaders, then cause-specific death rates of fewer than three deaths per 1000 livebirths from pneumonia and less than one death per 1000 livebirths from diarrhoea could be achieved by 2025. These rates are those at which preventable deaths have been avoided. Increasing of awareness of the size of the problem; strengthening of leadership, intersectoral collaboration, and resource mobilisation; and increasing of efficiency through the selection of the optimum mix of a growing set of cost-effective interventions depending on local contexts are the priority actions needed to achieve the goal of ending preventable deaths from pneumonia and diarrhoea by 2025.

AB - Global under-5 mortality has fallen rapidly from 12 million deaths in 1990, to 6·9 million in 2011; however, this number still falls short of the target of a two-thirds reduction or a maximum of 4 million deaths by 2015. Acceleration of reductions in deaths due to pneumonia and diarrhoea, which together account for about 2 million child deaths every year, is essential if the target is to be met. Scaling up of existing interventions against the two diseases to 80% and immunisation to 90% would eliminate more than two-thirds of deaths from these two diseases at a cost of US$6·715 billion by 2025. Modelling in this report shows that if all countries could attain the rates of decline of the regional leaders, then cause-specific death rates of fewer than three deaths per 1000 livebirths from pneumonia and less than one death per 1000 livebirths from diarrhoea could be achieved by 2025. These rates are those at which preventable deaths have been avoided. Increasing of awareness of the size of the problem; strengthening of leadership, intersectoral collaboration, and resource mobilisation; and increasing of efficiency through the selection of the optimum mix of a growing set of cost-effective interventions depending on local contexts are the priority actions needed to achieve the goal of ending preventable deaths from pneumonia and diarrhoea by 2025.

UR - http://www.scopus.com/inward/record.url?scp=84877578381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877578381&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(13)60319-0

DO - 10.1016/S0140-6736(13)60319-0

M3 - Article

C2 - 23582721

AN - SCOPUS:84877578381

VL - 381

SP - 1499

EP - 1506

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9876

ER -